About nateglinide
Meglitinide insulin-release stimulant
Used for
- Type 2 diabetes, alongside diet and exercise
Usual adult dose
Usually 120 mg three times daily, shortly before meals; skip a dose if skipping a meal.
Common side effects
- Low blood sugar
- Cold-like symptoms
- Diarrhea
- Dizziness
Important warnings
- Not for type 1 diabetes or diabetic ketoacidosis.
- Low blood sugar risk increases with missed meals, exercise, or other diabetes medicines.
- Use cautiously with liver disease.
- Check blood glucose as directed.
Pregnancy
Use only if clearly needed; insulin is generally preferred for diabetes during pregnancy.
Breastfeeding
Unknown whether it passes into breast milk; use caution and monitor the infant for low blood sugar.
Interactions
- Other diabetes medicines can increase low blood sugar risk.
- Some medicines may alter nateglinide levels, including gemfibrozil and rifampin.
- Alcohol may increase or prolong low blood sugar.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.